Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric pharmacokinetics and safety of gadoquatrane for contrast-enhanced MRI
jRCT2011230024Completed
- Sponsor
- Bayer
- Start
- Sep 2023
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of gadoquatrane in None, sponsored by Bayer. Primary endpoints: AUC of gadoquatrane, Plasma clearance normalized to body weight (CL/BW) and 2 more. Started Sep 2023; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on jRCT2011230024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011230024.